Enacitib

Sobre este medicamento

Originator: Idhifa by Bristol myers squibb · Manufacturer: Ziska Pharma. Indication & Dosage: Enacitib (Enasidenib), generic Idhifa is a prescription medicine used to treat patients with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatments. Enasidenib works by helping patient's bone marrow grow normal blood cells so patient will need fewer blood transfusions. Enacitib is manufactured by Ziska Pharma Ltd. in Bangladesh. Enasidenib has to take orally usually once daily with/ without food. Side Effects: The most common adverse reactions of Enasidenib are: Diarrhea , nausea , vomiting , change in taste, or loss of appetite The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.